Two competing influences that may explain concomitant tumor resistance

Area of Science:

• Oncology
• Immunology
• Cancer Biology

Background:

• A growing tumor can inhibit the development of a second tumor inoculum.
• This phenomenon, termed "concomitant immunity," is paradoxical as the first tumor continues to grow.
• Recent evidence suggests this may not involve a typical immune response.

Purpose of the Study:

• To re-evaluate the mechanism behind "concomitant immunity."
• To propose an alternative explanation for tumor growth inhibition in the presence of another tumor.
• To introduce the term "concomitant tumor resistance" for this phenomenon.

Main Methods:

• Review and consideration of existing observations on tumor interactions.
• Analysis of the interplay between local and systemic factors influencing tumor growth.
• Hypothesizing mechanisms based on diffusion and geometric considerations.

Main Results:

• Concomitant tumor resistance can occur without a recognizable immune reaction.
• The phenomenon is best explained by a balance between local tumor-facilitating factors and circulating tumor inhibitors.
• Larger tumors can overcome circulating inhibitors due to a stronger local facilitating environment.

Conclusions:

• "Concomitant tumor resistance" is a more accurate term than "concomitant immunity."
• Tumor growth is regulated by a dynamic interaction between local and systemic factors.
• Tumor size and geometry influence the effectiveness of these opposing factors.